Current approaches for Usher syndrome disease models and developing therapies

Area of Science:

• Genetics and Regenerative Medicine
• Ophthalmology and Audiology

Background:

• Usher syndrome is a severe genetic disorder causing progressive hearing and vision loss, often with vestibular issues.
• Recent advancements have focused on developing preclinical models to accelerate therapeutic development for Usher syndrome.
• Understanding the genetic basis is crucial for targeted interventions.

Purpose of the Study:

• To review recent progress in preclinical models for Usher syndrome.
• To highlight the role of induced pluripotent stem cells and organoid models.
• To provide an update on novel therapeutic strategies, including genetic therapies, in development and clinical trials.

Main Methods:

• Review of current literature on Usher syndrome preclinical models.
• Focus on induced pluripotent stem cell (iPSC) and organoid model development.
• Analysis of ongoing therapeutic strategies and clinical trial data.

Main Results:

• Significant progress in creating diverse preclinical models for Usher syndrome subtypes.
• Emergence of iPSC and organoid models offering new avenues for research.
• Advancement in genetic therapies and other novel treatments showing promise.

Conclusions:

• Preclinical models are crucial for advancing Usher syndrome therapies.
• Stem cell and organoid technologies are revolutionizing Usher syndrome research.
• Novel genetic therapies and ongoing clinical trials offer hope for patients.